AUG 01, 2020 11:27 PM PDT

Harnessing The Power of Synthetic Lethality

WRITTEN BY: Nouran Amin

Studies into genome sequencing has pushed researchers to harness the power of "synthetic lethality" in exploiting cancer-specific genetic defects and eventually identify therapeutic targets.  

Scientists at San Diego branch of Ludwig Institute for Cancer Research and University of California San Diego School of Medicine have observed that inhibition of a critical enzyme in cancer cells led to reduced tumor growth. These findings were examined in mouse models of breast and ovarian cancer. 

Results were reported in the Proceedings of the National Academy of Sciences (PNAS) and describe synthetic lethality is a result of non-lethal mutations become fatal when combined in cells. One model organism for this phenomenon is species of yeast, Saccharomyces cerevisiae, that provides an excellent genetic tool for synthetic lethal relationships. 

Learn more about synthetic lethality: 

 

Using these model organisms, researchers were able to pinpoint an enzyme referred to as Flap Endonuclease 1 (FEN1). The DNA structure-specific endonuclease is involved in repairing and replicating DNA. Specifically, blocking their function in cancer cells and will ultimately inhibit tumor growth. 

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 06, 2020
Immunology
The Coronavirus Is No Match Against Sybody 23
NOV 06, 2020
The Coronavirus Is No Match Against Sybody 23
The virus that causes COVID-19, SARS-CoV-2, uses its spike protein to gain access to cells, by binding to the ACE2 recep ...
NOV 15, 2020
Drug Discovery & Development
Antidepressant May Prevent Worsening of COVID-19 Infections
NOV 15, 2020
Antidepressant May Prevent Worsening of COVID-19 Infections
  Researchers from the Washington University School of Medicine in St. Louis have found that fluvoxamine, a common ...
DEC 15, 2020
Cannabis Sciences
Could Cannabis Help in the Opioid Crisis?
DEC 15, 2020
Could Cannabis Help in the Opioid Crisis?
While cannabis is increasingly available for medicinal use, doctors largely remain unable to prescribe it to their patie ...
DEC 18, 2020
Drug Discovery & Development
Lab-Induced Hallucinations Could Help Develop New Drugs
DEC 18, 2020
Lab-Induced Hallucinations Could Help Develop New Drugs
Researchers from the University of New South Wales in Australia have found that inducing hallucinations in healthy subje ...
DEC 20, 2020
Genetics & Genomics
A Repurposed Drug Can Treat a Genetic Disorder
DEC 20, 2020
A Repurposed Drug Can Treat a Genetic Disorder
Some researchers have sought to treat genetic diseases by correcting the mutation. But it may be possible to use another ...
JAN 18, 2021
Immunology
Arthritis Drug Approved for Critically Ill COVID Patients
JAN 18, 2021
Arthritis Drug Approved for Critically Ill COVID Patients
Critically ill COVID patients in the U.K. may receive an arthritis drug after a study showed that treatment lowered mort ...
Loading Comments...